Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Serrated adenoma of the colorectum and the DNA-methylator phenotype

Abstract

Serrated adenomas (SA) of the colorectum show features intermediate between hyperplastic polyps (HP) and adenomas. HP and SA are related lesions and there is now strong evidence for a 'serrated-polyp pathway' to colorectal cancer (CRC) that is largely independent of the classic adenoma-to-carcinoma sequence. A recently recognized lesion in this pathway is a HP variant characterized by relatively large size, atypical histology and proximal location in the colorectum. This HP variant has been given a variety of names in the literature including 'sessile SA' and 'type I SA'. Because this lesion lacks the traditional cytology of colorectal adenoma and in order to avoid confusion with SA, it is referred to in this review as sessile serrated polyp. SA are characterized by a heterogeneous group of changes at the molecular level, but a high proportion have BRAF mutations and DNA methylation. They may develop in HP or sessile serrated polyps, or may arise de novo. In the serrated-polyp pathway, the advent of genetic instability is likely to be an important rate-limiting step that drives rapid neoplastic evolution. Methylation and inactivation of the DNA repair genes MLH1 and MGMT (O-6-methylguanine-DNA methyltransferase) have been proposed as critical steps leading to genetic instability. Stretches of DNA rich in the bases guanine and cytosine (CpG islands; where p represents a phosphodiester bond linking adjacent cytosine and guanine bases) that are normally unmethylated may become methylated in malignant human colorectal tumors. Subsets of colorectal cancers with an unusually high number of methylated CpG islands have been described as having the 'CpG-island-methylator phenotype'. It is possible that many, if not all, CRCs with the CpG-island-methylator phenotype evolve through the serrated-polyp pathway that would, therefore, explain approximately 20% of all CRCs. The current lack of guidelines for managing serrated polyps may explain the static incidence of proximal CRC, despite the falling incidence rates for left-sided CRC during the same time period.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Microscopic views of polyp sections stained with hematoxylin and eosin, taken at the same magnification using a × 10 objective lens.

Similar content being viewed by others

References

  1. Hamilton SR and Aaltonen LA (2000) World Health Organization Classification of Tumours: Pathology and Genetics, Lyon: IARC Press

    Google Scholar 

  2. Kaye GI et al. (1973) Comparative electron microscopic features of normal, hyperplastic, and adenomatous human colonic epithelium. Variations in cellular structure relative to the process of epithelial differentiation. Gastroenterology 64: 926–945

    CAS  PubMed  Google Scholar 

  3. Muto T et al. (1975). The evolution of cancer of the colon and rectum. Cancer 36: 2251–2270

    Article  CAS  Google Scholar 

  4. Longacre TA and Fenoglio-Preiser CM (1990) Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14: 524–537

    Article  CAS  Google Scholar 

  5. Jass JR (2001) Serrated route to colorectal cancer: back street or super highway? J Pathol 193: 283–285

    Article  CAS  Google Scholar 

  6. Jass JR et al. (1984) A morphologic and histochemical study of metaplastic polyps of the colorectum. Cancer 53: 510–515

    Article  CAS  Google Scholar 

  7. Goldman H et al. (1970) Nature and significance of hyperplastic polyps of the human colon. Arch Pathol 89: 349–354

    CAS  PubMed  Google Scholar 

  8. Urbanski SJ et al. (1984) Mixed hyperplastic adenomatous polyps—an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol 8: 551–556

    Article  CAS  Google Scholar 

  9. Matsumoto T et al. (1999) Serrated adenoma of the colorectum: colonoscopic and histologic features. Gastrointest Endosc 49: 736–742

    Article  CAS  Google Scholar 

  10. Miwa S et al. (2005) Clinicopathologic differences among subtypes of serrated adenomas of the colorectum. Hepatogastroenterology 52: 437–440

    PubMed  Google Scholar 

  11. Rubio CA et al. (1996) Flat serrated adenomas of the colorectal mucosa in Japanese patients. In vivo 10: 339–344

    CAS  PubMed  Google Scholar 

  12. Komori K et al. (2003) Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol Int 53: 277–283

    Article  Google Scholar 

  13. Kang M et al. (1997) Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 21: 417–423

    Article  CAS  Google Scholar 

  14. Ban S (1999) Small hyperplastic polyps of the colorectum showing deranged cell organization: a lesion considered to be a serrated adenoma? Am J Surg Pathol 23: 1158–1160

    Article  CAS  Google Scholar 

  15. Mitomi H et al. (2003) Different apoptotic activity and p21WAF1/CIP1, but not p27Kip1, expression in serrated adenomas as compared with traditional adenomas and hyperplastic polyps of the colorectum. J Cancer Res Clin Oncol 129: 449–455

    Article  CAS  Google Scholar 

  16. Ladas SD et al. (2005) Cell turnover of serrated adenomas. J Pathol 206: 62–67

    Article  CAS  Google Scholar 

  17. Iino H et al. (1999) DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 52: 5–9

    Article  CAS  Google Scholar 

  18. Kudo T et al. (2004) Small invasive colonic cancer occurring in a hyperplastic polyp. Endoscopy 36: 825–828

    Article  CAS  Google Scholar 

  19. Oh K et al. (2005) Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 36: 101–111

    Article  CAS  Google Scholar 

  20. Otori K et al. (1997) High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40: 660–663

    Article  CAS  Google Scholar 

  21. Ajioka Y et al. (1998) Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut 42: 680–684

    Article  CAS  Google Scholar 

  22. Chan TL et al. (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63: 4878–4881

    CAS  PubMed  Google Scholar 

  23. Jass JR et al. (2002) Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862–876

    Article  CAS  Google Scholar 

  24. Kambara T et al. (2004) BRAF mutation and CpG island methylation: an alternative pathway to colorectal cancer. Gut 53: 1137–1144

    Article  CAS  Google Scholar 

  25. Tateyama H et al. (2002) Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 26: 249–256

    Google Scholar 

  26. Jass JR (2004) Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2: 1–8

    Article  Google Scholar 

  27. Torlakovic E et al. (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27: 65–81

    Article  Google Scholar 

  28. Biemer-Huttmann AE et al. (1999) Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem 47: 1039–1047

    Article  CAS  Google Scholar 

  29. Yao T et al. (1999) 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential. J Pathol 187: 511–517

    Article  CAS  Google Scholar 

  30. Cooper HS et al. (1979) Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum 22: 152–156

    Article  CAS  Google Scholar 

  31. Goldstein NS et al. (2003) Hyperplastic-like colon polyps that preceded microsatellite unstable adenocarcinomas. Am J Clin Pathol 119: 778–796

    Article  Google Scholar 

  32. O'Brien MJ et al. (2004) Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28: 423–434

    Article  Google Scholar 

  33. Torlakovic E and Snover DC (1996) Serrated adenomatous polyposis in humans. Gastroenterology 110: 748–755

    Article  CAS  Google Scholar 

  34. Lazarus R et al. (2005) The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol 123: 349–359

    Article  Google Scholar 

  35. Matsumoto T et al. (2002) Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation. Gut 50: 402–404

    Article  CAS  Google Scholar 

  36. Bonte H and Flejou JF (2003) Patterns of expression of MMR proteins in serrated adenomas and other polyps of the colorectum. Gut 52: 611

    Article  CAS  Google Scholar 

  37. Hiyama T et al. (1998) Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol 186: 131–139

    Article  CAS  Google Scholar 

  38. Fogt F et al. (2002) Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol 33: 87–91

    Article  Google Scholar 

  39. Uchida H et al. (1998) Genetic alterations of mixed hyperplastic adenomatous polyps in the colon and rectum. Jpn J Cancer Res 89: 299–306

    Article  CAS  Google Scholar 

  40. Sawyer EJ et al. (2002) Molecular characteristics of serrated adenomas. Gut 51: 200–206

    Article  CAS  Google Scholar 

  41. Yamamoto T et al. (2003) No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. Br J Cancer 89: 152–157

    Article  CAS  Google Scholar 

  42. Yang S et al. (2004) BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28: 1452–1459

    Article  Google Scholar 

  43. Park SJ et al. (2003) Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162: 815–822

    Article  CAS  Google Scholar 

  44. Konishi K et al. (2004) Molecular differences between serrated and conventional colorectal adenomas. Clin Cancer Res 10: 3082–3090

    Article  CAS  Google Scholar 

  45. Whitehall VL et al. (2001) Methylation of O-6-methylguanine-DNA methyltransferase characterizes a subset of colorectal cancer with low level DNA microsatellite instability. Cancer Res 61: 827–830

    CAS  PubMed  Google Scholar 

  46. Hawkins NJ and Ward RL (2001) Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93: 1307–1313

    Article  CAS  Google Scholar 

  47. Issa JP (2004) CpG island methylator phenotype in cancer. Nature Rev Cancer 4: 988–993

    Article  CAS  Google Scholar 

  48. Toyota M et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681–8686

    Article  CAS  Google Scholar 

  49. Hawkins N et al. (2002) CpG island methylation in sporadic colorectal cancer and its relationship to microsatellite instability. Gastroenterology 122: 1376–1387

    Article  CAS  Google Scholar 

  50. Whitehall VL et al. (2002) Morphological and molecular heterogeneity within non-microsatellite instability-high colorectal cancer. Cancer Res 62: 6011–6014

    CAS  PubMed  Google Scholar 

  51. Yamashita K et al. (2003) Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4: 121–131

    Article  CAS  Google Scholar 

  52. Chirieac LR et al. (2005) Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation. Am J Surg Pathol 29: 429–436

    Article  Google Scholar 

  53. Jass JR et al. (2000) Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47: 43–49

    Article  CAS  Google Scholar 

  54. Frazier ML et al. (2003) Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res 63: 4805–4808

    CAS  PubMed  Google Scholar 

  55. Young J et al. (2005) BRAF mutation and variable levels of microsatellite instability characterize a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 3: 254–263

    Article  CAS  Google Scholar 

  56. Beach R et al. (2005) BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166: 1069–1075

    Article  CAS  Google Scholar 

  57. Cox AD and Der CJ (2003) The dark side of Ras: regulation of apoptosis. Oncogene 22: 8999–9006

    Article  CAS  Google Scholar 

  58. Makinen MJ et al. (2001) Colorectal carcinoma associated with serrated adenoma—prevalence, histological features, and prognosis. J Pathol 193: 286–294

    Article  CAS  Google Scholar 

  59. Higuchi T and Jass JR (2004) My approach to serrated polyps of the colorectum. J Clin Pathol 57: 682–686

    Article  CAS  Google Scholar 

  60. Eide TJ (1986) Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38: 173–176

    Article  CAS  Google Scholar 

  61. Yamauchi T et al. (2002) Serrated adenoma developing into advanced colon cancer in 2 years. J Gastroenterol 37: 467–470

    Article  Google Scholar 

  62. Rabeneck L et al. (2003) Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 98: 1400–1409

    PubMed  Google Scholar 

  63. Arao J et al. (2001) Cyclooxygenase-2 is overexpressed in serrated adenoma of the colorectum. Dis Colon Rectum 44: 1319–1323

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Canadian Institutes of Health Research, through funding of the project 'Serrated Polyps and Colorectal Cancer' (MOP-67206).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeremy R Jass.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

DYSPLASIA

A structural abnormality at the cell and tissue level that may be precancerous

ANOIKIS

A type of apoptosis, of cells that have lost contact with the extracellular matrix or that interact with the matrix through an inappropriate integrin–matrix combination

GOBLET CELLS

Specialized mucus-secreting epithelial cells that are found in the mucous membranes of the intestinal and respiratory tracts

MUTL HOMOLOG 1 (MLH1)

A DNA mismatch repair gene found on chromosome 3p that accounts for a large proportion of hereditary nonpolyposis colorectal cancers

BIMODAL DISTRIBUTION

A statistical term that describes the distribution of two distinct sets of values that measurements tend to center around

ANEUPLOIDY

Cell population that has additions or deletions of whole chromosomes from the expected balanced diploid number of chromosomes

RAS ASSOCIATION (RALGDS/AF-6) DOMAIN FAMILY 1 (RASSF1)

Encodes a protein similar to the Ras effector proteins; loss or altered expression of this gene is associated with the pathogenesis of a variety of cancers and correlates with the hypermethylation of its CpG-island promoter region

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jass, J. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Rev Clin Oncol 2, 398–405 (2005). https://doi.org/10.1038/ncponc0248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0248

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing